感謝Pharma Boardroom報導:Little Fish, Big Pond: Growing a Taiwanese Medtech Startup Internationally

感謝英國知名調研機構Pharma Boardroom報導!

安盛再結合醫療及通訊產業不遺餘力,可在此媒體上分享趨勢洞見,實為我們的榮幸!

iXensor is devoted to leveraging the power of Point-of-Care (POC) diagnostics to provide a comprehensive mobile health solution across a variety of essential health areas. “We originally started iXensor in glucose management exclusively. However, with our technology platform, we were able to expand our offering and allow consumers to use their smartphone to test for several different biomarkers,” explains Carson Chen, the company’s co-founder and chief technology officer (CTO).

Alan Tsai, iXensor’s other co-founder and general manager adds, “Currently, our technology platform covers three areas: chronic disease, women’s health, and infectious disease.” With this platform, patients and healthcare professionals can monitor ovulation cycles, blood sugar levels, and conduct rapid tests of transmittable diseases, such as zika and dengue with the same device.

(節錄本文:https://pharmaboardroom.com/articles/little-fish-big-pond-growing-a-taiwanese-medtech-startup-internationally/)

發表迴響

你的電子郵件位址並不會被公開。 必要欄位標記為 *